About the Researcher

Gary S. Goldman holds a Ph.D. in Computer Science from Pacific Western University in Los Angeles and graduated with honors in 1977 from California State University, Fullerton (CSUF) with a double major: B.S. Engineering (Electronic emphasis) and B.S. Computer Science. He was elected member of the Phi-Kappa-Phi honor society and in 1976 received the Outstanding University Engineering Student Award, presented by the Orange County Engineering Education Council (OCEC). At graduation he received a special Merit Award in recognition of scholarly commitment and outstanding Academic Achievement in Computer Science, presented by CSUF.

At CSUF, Goldman was employed as a computer consultant assisting faculty and staff. He later served as a part-time assistant professor for the Engineering and Quantitative Methods departments instructing both graduate and undergraduate courses in statistics, programming, digital simulation, and digital logic design and switching theory.

Patented "Power Wheel"

In 1980, as vice-president of Systems Development of Cascade Graphics Development, he developed the first microcomputer-based computer-aided drafting (CAD) system (prior to the well known AutoCad product; see figure). This system used an Apple II to process user inputs and a 68000 microprocessor to perform real time graphics. Dr. Gilbert McCann, then professor emeritus of CalTech, served on the board of directors of this company. Goldman engaged in computer consulting tours to South Africa, Germany, Holland, England and Canada. Goldman holds a U.S. patent (#4223255, granted September, 1980) for a micro-programmed, high-efficiency motor-in-a-wheel called “Power Wheel,” for use in electric vehicular applications. This invention was featured on the front cover of the Fall, 1980 issue of Science and Mechanics (see figure).

Goldman, V.P. Cascade Graphics Dev.,
with First CAD System in 1980.

After operating one year independently, Cascade Graphics Development was acquired by an international petrochemical company. In the early 1980’s, Dr. Goldman assisted with the integration of the graphics system and voice input Technology. This product, unique for its time, permitted disabled persons to be productive and generate high quality drawings. He recalls hiring a quadriplegic who accomplished fulfilling and productive work on this system. Dr. Goldman automated the design of vertical cylindrical heaters, including convection coil design and tube-wall thickness calculations for the piping. Dr. Goldman wrote a heuristic program that designed earth retaining walls with and without traffic loads and provided the complete materials list and drawing for the project. Goldman’s program could produce a 100-foot long wall along any given terrain in five minutes—a task that previously took several engineers an entire week to accomplish. He also developed a specialized curve fitting routine, used by pilot Burt Rutan, suitable for aircraft wing design.

Gary S. Goldman, Vice-President
Cascade Graphics Development

He co-developed with (Heidi BlakE) the Goldman/Blake remediation program for children with specific visual process deficits; this program was used in a pilot study at the Hope-Haven Hospital in Florida. In 1976, he served on a development team that produced the first Interactive Graphics Terminal, IGT-100, at CalComp (California Computer Products, Anaheim, CA) This system allowed drawings to be edited prior to their being electronically plotted.

For 30 plus years, Goldman has served as a computer consultant responsible for the automation of a wide variety of businesses, improved production, and conversion of databases. He has authored and presented numerous manuscripts contributing to engineering and computer science disciplines and enjoys writing heuristic programs (developing algorithms based on ones knowledge and intuition concerning a problem).

Dr. Goldman served for eight years (from January, 1995 until his resignation in October of 2002) as Research Analyst for the Varicella Active Surveillance Project (VASP) in Antelope Valley, in a cooperative project with the Centers for Disease Control and Prevention (CDC, Atlanta, GA). He developed a model that quantified the seasonal variation in chickenpox based on school enrollment (clustering) and high ambient air temperature. Additionally, he created a database and data entry programs for several hundred demographic and clinical variables pertaining to chickenpox and shingles. This included logic to detect case duplicates (important for application of capture-recapture methods) and link cases originating from the same household. He also supplied the initiative and background material for the proposal to add shingles to the active surveillance program. Additionally, he wrote statistical analyses to (a) investigate 2nd varicella infections (later published in peer-reviewed medical journal), (b) study varicella susceptibility (presented at a symposium and published later outside VASP), (c) quantify transmission of varicella in households, (d) determine chickenpox vaccine efficacy by year (published later outside VASP), (e) track outbreaks of chickenpox in schools, (f) perform a cost-benefit analysis of universal varicella vaccination taking into account the closely related herpes zoster epidemiology (published later outside VASP), and (g) perform capture-recapture to measure reporting completeness of chickenpox cases to the surveillance project (published in The Journal of the American Medical Association--JAMA). Finally, Goldman computed both (1) true shingles incidence rate among children with previous histories of chickenpox and (2) true shingles incidence rate among vaccinated children so as to investigate trends in shingles incidence in a community under moderate to widespread varicella vaccination (published later outside VASP).

Presently, Dr. Goldman serves as a consulting computer scientist and is on the board of directors of Pearblossom Private School, Inc. which provides distance education to over 1,500 independent study students each year in grades K through 8 throughout the United States (see www.PearblossomSchool.com). Dr. Goldman also is a licensed and credentialed teacher for 7-12th grade mathematics and provides technology updates and programs for Pearblossom Academy, Inc. which supports high school students in an accredited course of instruction (see www.PearblossomAcademy.com).

From 2004 through 2010 he served as Editor-in-Chief of the peer-reviewed journal, Medical Veritas: The Journal of Medical Truth (see www.MedicalVeritas.com). Through this endeavor Dr. Goldman has had the pleasure of interfacing with world-renowned scientists, researchers, and physicians.

Dr. Goldman has served as a reviewer for the Journal of the American Medical Association (JAMA), Human and Experimental Toxicology (HET), Vaccine, The American Journal of Managed Care (AJMC), Expert Review of Vaccines (ERV), Expert Review of Dermatology (ERD), Journal of the European Academy of Dermatology and Venereology (JEADV), Epidemiology and Infection, The Open Allergy Journal, BioMed Research International (Biomed Res Int), Epidemology & Infection, Therapeutic Advances in Vaccines and Immunotherapy, and British Medical Journal (BMJ). He is included on the Editorial Board of Research and Reviews in BioSciences.

CDC Certificate of AcheivementLetter from ACDC Chief
1995 Certificate from Walter A. Orenstein, MD
Director, National Immunization Program, CDC
Commendation Letter from
Chief of Acute Communicable Disease Control

Recent Medical Publications, Abstracts, etc.

[1] Assessing the Impact of Vaccination on the Incidence of Vaccine Preventable Diseases via Harmonic Regression. Presented May 23, 2000 by John W. Glasser (CDC). GS Goldman, JW Glasser, TJ Maupin, CL Peterson, . Mascola, RT Chen, and JF Seward.

[2] The impact of vaccination on varicella incidence, conditional on school attendance and temperature, in Antelope Valley, CA. Goldman GS, Glasser JW, Maupin TJ, Peterson CL, Mascola L, Chen RT, and Seward JF. Presentation by J.W. Glasser at 16th International Conference on Pharmacoepidemiology (ICPE); Barcelona, Spain; August 22, 2000; Pharmacoepidemiology and Drug Safety; 9(Suppl 1):S67.

[3] Varicella active surveillance: use of capture-recapture methods to assess completion of surveillance data. Peterson CL, Maupin T, Goldman G, Mascola L. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. September 28 - October 1, 1997, Toronto, Canada; Abstract H-111, page 233.

[4] Decline in varicella incidence and hospitalizations in sentinel surveillance areas in the United States, 1995-2000. Seward J, Watson B, Peterson C, Mascola L, Pelosi J, Zhang J, Jumaan A, Maupin T, Goldman G, Perella D, Waites C, Tabony L, Wharton M. The 4th International Conference on VZV, March 3-5, 2001, Oral Presentation, La Jolla, California. VZV Research Foundation in partnership with Columbia University College of Physicians and Surgeons.

[5] Breakthrough varicella cases since vaccine licensure in the Varicella Active Surveillance Project. April 2001 Supplement of Pediatric Research, Presented April 28-May 1, 2001 Pediatric Academic Societies Meeting, Baltimore, Maryland. Galil K, Watson B, Peterson C, Mascola L, Pelosi J, Seward J, Zhang J, Maupin T, Goldman G, Perella D, Waites C, Tabony L, Wharton M. Centers for Disease Control and Prevention, Atlanta, GA; Philadelphia Department of Public Health, Philadelphia, PA; Los Angeles County Department of Health, Los Angeles, CA; Texas Department of Health, Austin, TX; Dyntel Corporation, Atlanta, GA. Publication no. 843.

[6] Knowledge, attitudes, and practices of healthcare providers regarding varicella vaccination in sentinel surveillance area, 1996, 1997, and 1999. Maupin T, Goldman G, Peterson C, Mascola L, Seward J. Poster Session, April 28-May 1 2001, Pediatric Academic Society Annual Meeting, Baltimore, Maryland.

[7] Varicella Epidemiology: six years of active surveillance data following implementation of the varicella vaccination program. Peterson C, Mascola L, Maupin T, Goldman G, Seward J, Presented at the 39th Annual Meeting of the Infectious Diseases Society of America (IDSA), Abstract 943, October 25-28, 2001; San Francisco, California.

[8] Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. Seward JF, Watson BM, Peterson CL, Mascola L, Pelosi JW, Xhang JX, Maupin TJ, Goldman GS, Tabony LJ, Brodovicz KG, Jumaan AO, Wharton M. JAMA 2002; 287(5):606–11.

[9] Second varicella infections: are they more common than previously thought? Hall S, Maupin T, Seward J, Jumaan AO, Peterson C, Goldman G, Mascola L, Wharton M. Pediatrics. 2002 Jun;109(6):1068–73.

[10] Varicella susceptibility among adolescents in an active surveillance site. Maupin T, Goldman G, Peterson C, Mascola L, Seward J, Jumaan A, 36th National Immunization Conf. of the CDC, 05/01/02, Denver, CO.

[11] Varicella susceptibility and incidence of herpes-zoster among children and adolescents in a community under active surveillance. Goldman G. Vaccine, 2003 Oct. 1; 21(27-30):4238–42.

[12] Incidence of herpes-zoster among children and adolescents in a community with moderate varicella vaccination coverage. Goldman G. Vaccine, 2003 Oct. 1; 21(27-30):4243–9.

[13] Using capture-recapture methods to assess varicella incidence in a community under active surveillance. Goldman G. Vaccine, 2003 Oct 1; 21(27-30):4250–55.

[14] Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology. Goldman G. Vaccine, 2005 May; 23(25):3349–55.

[15] An investigation of the association between MMR vaccination and autism in Denmark. Goldman G, Yazbak EF, Journal of Association of American Physicians and Surgeons, Fall 2004; 9(3):70–5.

[16] Response to Letter to Editor by Jumaan: Goldman’s role in the Varicella Active Surveillance Project. Goldman GS. Vaccine, 2004 Sep 3; 22(25-26):3232–6. (doi:10.1016/j.vaccine.2004.07.001)

[17] Annual Summary, Each year 1995 through 2001, Antelope Valley Varicella Active Surveillance Project (VASP), Los Angeles County Department of Health Services (LACDHS); Centers for Disease Control and Prevention (CDC) Cooperative Agreement No. U66/CCU911165-10; Maupin T, Goldman G, Peterson C, Mascola L.

[18] Universal varicella vaccination: Efficacy trends and effect on herpes-zoster. Goldman GS. International Journal of Toxicology, 2005 July-Aug.;24(4):205–13.

[19] The Case against Universal Varicella Vaccination. [Commentary] Goldman GS. International Journal of Toxicology, 2006 Sept.-Oct.,25(5):313–17.

[20] Infant mortality rates regressed against number of vaccine doses routinely given: Is there a biochemical or synergistic toxicity? Miller NZ, Goldman GS. Hum Exp Toxicol., 2011 Sept.; 30(9):1420–8. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170075/pdf/10.1177_0960327111407644.pdf

[21] Relative trends in hospitalizations and mortality among infants by number of vaccine doses and age, based on the Vaccine Adverse Event Reporting System (VAERS), 1990-2010. Goldman GS, Miller NZ. Hum Exp Toxicol 2012 Oct; 31(10):1012–21.

[22] Comparison of VAERS fetal-loss reports during three consecutive influenza seasons: Was there a synergistic fetal toxicity associated with the two-vaccine 2009/10 season? Goldman GS. Hum Exp Toxicol 2012 Oct;31(10):1012–21.

[23] Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy primarily based primarily on the Antelope Valley Varicella Active Surveillance Project data. Goldman GS, King PG. Vaccine 2012; 31(13):1680–94; http://dx.doi.org/10.1016/j.vaccine.2012.05.050

[24] Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data. Goldman GS, King P. Hum Exp Toxicol., 2014 Aug. 33(8):886–93. PMID: 24275643.

[25] Case Study: Varicella Vaccine and the Suppression of Data. Miller NZ, Goldman GS. Journal of American Physicians and Surgeons, Spring 2022; 27(1):15–20.

[26] Insights on the impact of external and internal boosting on varicella-zoster virus reactivation based on evidence from the first decade of the United States universal varicella vaccination program. Goldman GS. Cureus, 2021 Aug. 6; 13(8):e16963. doi: 10.7759/cureus.16963

[27] Interview with Gary Goldman, Ph.D., on CDC suppression of undesirable vaccine data. Miller NZ. Available at http://thinktwice.com/interivew-with-Gary-Goldman.pdf

[28] Examples of output reporting bias in vaccine studies: illustrating how medical consensus can impede progress in public health. Goldman GS. Cureus, 2022 Sep. 21; 14(9):e29399. doi: 10.7759/cureus.29399

[29] Reaffirming a positive correlation between number of vaccine doses and infant mortality rates: a response to critics. Goldman GS, Miller NZ. Cureus 2023 Feb. 2; 15(2):e34566. doi: 10.7759/cureus.34566

[30] Neonatal, infant, and under age five vaccine doses routinely given in developed nations and their association with mortality rates. Miller NZ, Goldman GS. Cureus 2023 Jul. 20; 15(7):e42194. doi: 10.42194/cureus.42194

Engineering and CAD Publications

[1] Artificial Intelligence, abstract published and presented at the 4th Annual ACM (Association of Computer Machinery) Computer Science Conference, Feb 12, 1976 Anaheim, CA.

[2] PRISM: An Educational Aide to Symbolic Differentiation and Simplification of Algebraic Expressions, COED (Computers in Education, Division of ASEE), Transactions, Vol. IX, No. 2, 1977, pages 13-32; also presented and published at the WESCON (Western Electric Show and Convention), Los Angeles Convention Center, September 17, 1976.

[3] A FORTRAN IV Implementation for the Numerical Determination and Mohr Diagram Representation of the Triaxial State of Stress at Point, COED (Computers in Education, Division of the American Society of Engineering Education), Application Note No. 42, 1977.

[4] Constructing Stylish Characters on Computer Graphics Systems, Computers in Education Division of ASEE (COED); Vol. XII, No. 11, 1980, pages 111-122.

[5] Computer Aided Design Analysis of Safety Factors Based on Theories of Failure, 1977 Symposium on Application of Computer Methods in Engineering.

[6] IGL (Interactive Graphics Language) Reference Manual, CalComp Systems Division, Manual No. 116e, Nov., 1978.

[7] IGL (Interactive Graphics Language) Procedures Library, CalComp Systems Division, Manual No. 1164, Nov., 1978.

[8] The Power Wheel--Elimination of Energy Consuming Drive Components, presented and published at the IEEE (Institute of Electrical and Electronics Engineers) Region V Annual Conference, “Energy 1978", Tulsa, Oklahoma, April 15-17, 1978; IEEE Cat. No. 78Ch1283-1, pp. 95-99, Tulsa, OK.

[9] Electromotive Torque for Vehicular Applications, presented and published at the 28th IEEE Vehicular Technology Conference, pp. 119-132, March 22-24, 1978; Denver, CO.

[10] Wheel Hub Motors Applied to Electric Vehicle Propulsion, 14th Intersociety Energy Conversion Engineering Conference (IECEC), published by America Chemical Society, Volume 1, pp. 632-636, Aug. 5-10, 1979; Boston, MA

[11] Field Study of the Goldman-Blake Remediation System and Its Effectiveness with Visually Impaired Children, Hope Haven Association/The Florida School for the Deaf and Blind, 1979.

[12] A Heuristic Algorithm for Intersection Cleanup--Implemented in IGL, Copyright 1979, Computers in Education, Division of the American Society for Engineering Education (COED), P.O. Box 308, West Long Branch, NJ 07764; Also published in Proceedings of COMPSAC79, The IEEE Computer Society's Third International Computer Software & Applications Conference, IEEE Catalog No. 79CH1515-6C, pp. 757-762, Nov. 6-8, Chicago, IL.

[13] The Power Wheel, front cover feature in the Fall, 1980 issue of the journal Science and Mechanics.

[14] MDAS: Mechanical Design Application Software, Copyright ©1981 by Cascade Graphics Development.

[15] A New Era In Computer Aided Drafting, Copyright ©1982 by Cascade Graphics Development.

[16] PGL: Pascal Graphics Library, Programmer's Guide, Copyright ©1983 by Cascade Graphics Development.

[17] Cascade V/X Reference Manual, Copyright ©1984 Cascade Graphics Development; User's Manual complete with glossary, description of graphics tasks, and tutorial.

[18] ASAP: Architectural Software Application Package, Copyright ©1984 by Cascade Graphics Development.

[19] Micro-based CAD: A production Tool for Manufacturing Engineering, Computer Graphics Applications for Management and Productivity (CAMP 1984), West Berlin, Germany, Sept. 25-26, 1984, pp. 1-22; Also, Microprocessor Seminar Proceedings of the American Production and Inventory Control Society (APICS), Jan. 30-Feb. 1, 1984, Palm Springs, CA, pp. 74-83.